Literature DB >> 17069348

The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol.

Irene F Gazi1, Theodosios D Filippatos, Vasilis Tsimihodimos, Vasilios G Saougos, Evangelos N Liberopoulos, Dimitri P Mikhailidis, Alexandros D Tselepis, Moses Elisaf.   

Abstract

The hypertriglyceridemic waist (HTGW) phenotype (hypertriglyceridemia and increased waist circumference) has been proposed as an inexpensive tool to monitor individuals with the atherogenic metabolic triad, hyperinsulinemia, hyperapobetalipoproteinemia, and increased levels of small, dense LDL (sdLDL) particles. We assessed the association of the HTGW phenotype with the metabolic syndrome (MetSyn) and the atherogenic metabolic triad in inhabitants (n = 260) of northwestern Greece attending the Outpatient Lipid Clinic of the University Hospital of Ioannina. The LDL subfractions were assessed using the Lipoprint LDL System. HTGW (+) individuals had a more adverse lipid and lipoprotein profile compared with HTGW (-) individuals. Moreover, HTGW (+) subjects had elevated levels of sdLDL-C, as well as decreased mean and peak LDL particle size compared with HTGW (-) subjects. To our knowledge, this is the first report documenting the sdLDL-C abnormality in HTGW (+) subjects. Among men (n = 105), 52.3% of the MetSyn (+) individuals and 66.7% of the HTGW (+) individuals had the metabolic triad. Among women (n = 155), the corresponding percentages were 42.3% and 50.0%. Only 22.2% and 10.6% of the MetSyn (-) subjects (men and women, respectively) and 19.6% and 15.2% of the HTGW (-) subjects (men and women, respectively) had the atherogenic metabolic triad. In conclusion, the HTGW (+) phenotype is associated with a hostile lipid profile that includes higher levels of sdLDL-C and decreased LDL particle size. The HTGW phenotype, compared with the MetSyn criteria, can provide an easy and inexpensive tool to monitor patients characterized by an adverse lipid and lipoprotein profile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17069348     DOI: 10.1007/s11745-006-5015-8

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System.

Authors:  D M Hoefner; S D Hodel; J F O'Brien; E L Branum; D Sun; I Meissner; J P McConnell
Journal:  Clin Chem       Date:  2001-02       Impact factor: 8.327

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria.

Authors:  Irene Gazi; Vasilis Tsimihodimos; Theodosios Filippatos; Eleni Bairaktari; Alexandros D Tselepis; Moses Elisaf
Journal:  Metabolism       Date:  2006-07       Impact factor: 8.694

4.  Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects.

Authors:  Haralampos J Milionis; Evangelos Rizos; John Goudevenos; Konstantinos Seferiadis; Dimitri P Mikhailidis; Moses S Elisaf
Journal:  Stroke       Date:  2005-06-02       Impact factor: 7.914

5.  Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

Authors:  I Lemieux; A Pascot; C Couillard; B Lamarche; A Tchernof; N Alméras; J Bergeron; D Gaudet; G Tremblay; D Prud'homme; A Nadeau; J P Després
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

6.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Authors:  B Lamarche; A Tchernof; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

7.  Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.

Authors:  Irene Gazi; Evangelia S Lourida; Theodosios Filippatos; Vasilis Tsimihodimos; Moses Elisaf; Alexandros D Tselepis
Journal:  Clin Chem       Date:  2005-10-13       Impact factor: 8.327

8.  Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.

Authors:  Jacqueline M Dekker; Cynthia Girman; Thomas Rhodes; Giel Nijpels; Coen D A Stehouwer; Lex M Bouter; Robert J Heine
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

9.  Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men.

Authors:  T Kazumi; A Kawaguchi; T Hozumi; M Nagao; M Iwahashi; M Hayakawa; K Ishihara; G Yoshino
Journal:  Atherosclerosis       Date:  1999-01       Impact factor: 5.162

Review 10.  Prevention and treatment of the metabolic syndrome.

Authors:  S S Daskalopoulou; D P Mikhailidis; M Elisaf
Journal:  Angiology       Date:  2004 Nov-Dec       Impact factor: 3.619

View more
  8 in total

Review 1.  Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?

Authors:  Aris P Agouridis; Christos V Rizos; Moses S Elisaf; Theodosios D Filippatos
Journal:  Rev Diabet Stud       Date:  2013-08-10

2.  The "hypertriglyceridemic waist" phenotype and glucose intolerance in pregnancy.

Authors:  Diane Brisson; Patrice Perron; Simon-Pierre Guay; Daniel Gaudet; Luigi Bouchard
Journal:  CMAJ       Date:  2010-09-20       Impact factor: 8.262

Review 3.  Dapagliflozin in patients with type 2 diabetes mellitus.

Authors:  Theodosios D Filippatos; Evangelos N Liberopoulos; Moses S Elisaf
Journal:  Ther Adv Endocrinol Metab       Date:  2015-02       Impact factor: 3.565

Review 4.  Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?

Authors:  Isabelle Lemieux; Paul Poirier; Jean Bergeron; Natalie Alméras; Benoît Lamarche; Bernard Cantin; Gilles R Dagenais; Jean-Pierre Després
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

5.  The effect of insulin resistance and obesity on low-density lipoprotein particle size in children.

Authors:  Mehmet Emre Taşcılar; Tolga Özgen; Murat Cihan; Ayhan Abacı; Ediz Yeşilkaya; Ibrahim Eker; Muhiddin Serdar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-05-02

6.  The association of hypertriglyceridemic waist phenotype with type 2 diabetes mellitus among individuals with first relative history of diabetes.

Authors:  Massoud Amini; Ahmad Esmaillzadeh; Marzieh Sadeghi; Najmahe Mehvarifar; Marzieh Amini; Maryam Zare
Journal:  J Res Med Sci       Date:  2011-02       Impact factor: 1.852

7.  Predictors of metabolic abnormalities in phenotypes that combined anthropometric indices and triglycerides.

Authors:  Bum Ju Lee; Jiho Nam; Jong Yeol Kim
Journal:  BMC Complement Altern Med       Date:  2016-02-10       Impact factor: 3.659

8.  The association between "hypertriglyceridemic waist" and sub-clinical atherosclerosis in a multiethnic population: a cross-sectional study.

Authors:  Danijela Gasevic; Axel C Carlsson; Iris A Lesser; Gb John Mancini; Scott A Lear
Journal:  Lipids Health Dis       Date:  2014-02-23       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.